Ketamine Infusion vs Spravato: Key Differences

Table of Contents

• Ketamine Infusion vs Spravato: A Quick Comparison
• FDA-Approved Esketamine Treatment: What Makes Spravato Different
• How Ketamine Infusion Works as an Off-Label Option
• Administration Methods: IV Drip vs Nasal Spray
• Effectiveness for Treatment-Resistant Depression
• Cost of Spravato vs Ketamine: Insurance and Out-of-Pocket
• Side Effects and Safety Monitoring
• How to Prepare for a Ketamine Infusion or Spravato Session
• Which Treatment Fits Your Situation?
• Frequently Asked Questions

Last Updated: September 16, 2026

Ketamine Infusion vs Spravato: A Quick Comparison

The difference between ketamine infusion and Spravato comes down to one word: approval. Spravato is an FDA-approved esketamine nasal spray with a defined indication, a monitoring protocol, and a path to insurance coverage. IV ketamine infusion is generic ketamine used off-label, delivered directly into the bloodstream, and almost always paid for out of pocket. Both can help people whose depression has not responded to standard medications, but they are regulated, dosed, and billed in completely different ways.

At Solid Foundation Psychiatry, we walk patients through this exact decision regularly, and the honest answer is that neither option wins across the board. The right choice depends on your insurance situation, how quickly you need relief, and how much time you can commit to in-office monitoring.

Here is the short version before we get into the details:

Feature	IV Ketamine Infusion	Spravato (Esketamine)
FDA status	Off-label for depression	FDA-approved for treatment-resistant depression
Administration	Intravenous drip	Nasal spray
Typical coverage	Rarely covered, out of pocket	Often covered by commercial insurance and Medicare
Monitoring	Physician-supervised, clinic-specific	Mandatory REMS program sessions
Dose control	Fully customizable by physician	Fixed, standardized dosing

FDA-Approved Esketamine Treatment: What Makes Spravato Different

Spravato is the only form of ketamine-based therapy with an FDA indication specifically for treatment-resistant depression in adults. That approval changes everything downstream: how it is dosed, who can administer it, and whether your insurer will pick up the bill.

The drug itself is esketamine, a single isomer of ketamine, delivered as a nasal spray. Because it carries an approved indication, it falls under a Risk Evaluation and Mitigation Strategy program, commonly called REMS. In practice, that means every session happens in a certified clinic, you stay for a set observation period afterward, and your dose is standardized rather than tailored session by session.

That standardization cuts both ways. It makes Spravato predictable and easier to get covered, and it removes some of the flexibility a physician has with an IV drip. You can read the manufacturer’s own clinical information through the Spravato prescribing information and REMS program details.

How Ketamine Infusion Works as an Off-Label Option

IV ketamine infusion is generic ketamine given through an intravenous line, and it is used off-label for depression and other mood conditions. Off-label does not mean unproven or unregulated in a dangerous sense. It means the FDA has not formally approved this specific drug for this specific use, so the manufacturer cannot market it that way and insurers have no obligation to cover it.

What you gain is control. A physician can adjust the infusion rate, total dose, and session length based on how you respond, which matters for patients who have already failed multiple medication trials. What you lose is the standardized safety net that comes with an approved product. Monitoring still happens, but the protocol is set by the clinic rather than by a federal risk program.

The FDA’s explanation of off-label drug use is worth reading if the phrase makes you uneasy. It is a common, legal, and long-established part of medical practice.

Administration Methods: IV Drip vs Nasal Spray

The delivery method shapes the entire experience, from how fast relief may arrive to how long you sit in a chair afterward. IV ketamine goes directly into the bloodstream, which means near-complete absorption and a rapid onset. Spravato is absorbed through the nasal lining, which is less predictable but still fast compared with oral antidepressants.

Here is how a typical session differs:

• IV ketamine: You sit or recline while an IV line delivers the drug over roughly 40 minutes to an hour, with monitoring throughout and a recovery period afterward.
• Spravato: You self-administer the nasal spray under supervision, then remain in the clinic for observation before you are cleared to leave.

Neither is a take-home treatment. Both require a clinical setting, and neither should be driven to or from on the day of your session. The practical difference is that IV sessions tend to be longer per visit, while Spravato’s REMS rules lock in a fixed observation window regardless of how you feel.

Effectiveness for Treatment-Resistant Depression

Both approaches target the same population: adults who have not gotten adequate relief from standard antidepressants. The clinical reasoning behind both is that ketamine acts on glutamate signaling rather than the serotonin pathways most conventional antidepressants target, which is why relief can arrive in days rather than weeks.

Where they diverge is in the evidence base. Spravato has gone through the FDA’s randomized trial process for its specific indication, which is why it can make formal efficacy claims. IV ketamine has a substantial body of published research behind it, including work supported by the National Institute of Mental Health on ketamine and depression, but it has not been through that same approval pathway for depression.

In practice, many clinicians view the two as overlapping tools rather than rivals. Some patients respond better to one than the other, and response is not something you can predict from a chart. It is something you find out by trying, under supervision, with a clinician adjusting as you go.

Cost of Spravato vs Ketamine: Insurance and Out-of-Pocket

Cost is where the two paths separate most sharply, and it is the question we hear most often. Spravato is frequently covered by commercial insurance and Medicare, with patient copays that are often modest once coverage is confirmed. IV ketamine is almost always a fee-for-service arrangement, paid directly by the patient.

The reasons are structural, not arbitrary. Spravato has an FDA-approved indication and a billing code insurers recognize. Generic IV ketamine for depression does not, so there is no standard coverage pathway for it. That does not mean coverage is automatic for Spravato either. Plans vary, prior authorization is common, and you should verify your specific benefits before assuming anything. The Centers for Medicare & Medicaid Services publishes coverage guidance that can help you understand how these decisions get made.

Book Appointment →

Because pricing depends on your plan, your dose, and the number of sessions recommended, we do not quote figures here. Solid Foundation Psychiatry verifies benefits and walks patients through the actual numbers during a consultation rather than guessing at them beforehand.

Side Effects and Safety Monitoring

Both treatments carry real side effects, and both require monitoring. The most commonly reported effects during and shortly after a session include dissociation, a temporary rise in blood pressure, nausea, dizziness, and sedation. These typically ease as the drug clears, which is exactly why the observation period exists.

Safety monitoring looks different in each case:

• Spravato: Follows the REMS protocol, with a fixed observation window and blood pressure checks at set intervals.
• IV ketamine: Follows the treating clinic’s own protocol, which may be more or less intensive depending on the practice.

Neither treatment is appropriate for everyone. Uncontrolled high blood pressure, certain cardiovascular conditions, and a history of psychosis are among the factors a clinician will screen for. This is not a treatment you should pursue without a full psychiatric evaluation, and no responsible clinic will offer it without one.

How to Prepare for a Ketamine Infusion or Spravato Session

Preparation is more practical than complicated, and it makes the day go more smoothly. The core steps are the same whether you are scheduled for an IV infusion or a Spravato session.

Here is a checklist to work through before your appointment:

• Arrange a ride home. You will not be cleared to drive yourself.
• Clear your schedule for the rest of the day. Do not plan to work or make decisions afterward.
• Confirm your medication list with your clinician, especially anything affecting blood pressure.
• Ask whether to eat beforehand, since guidance varies by clinic and protocol.
• Bring a list of questions, including what to do if you feel unwell at home.
• Confirm your insurance or payment arrangement in advance so there are no surprises.

If you are preparing for a ketamine infusion specifically, expect a longer visit than a nasal spray session. Wear comfortable clothing, bring something to pass the recovery time, and plan a low-key evening.

Which Treatment Fits Your Situation?

If insurance coverage is your deciding factor, Spravato is usually the more accessible path. If your clinician wants precise control over dosing and you can pay out of pocket, IV ketamine offers flexibility that the nasal spray cannot match. Neither is universally better, and anyone who tells you otherwise is oversimplifying.

For patients in Pearland, the more useful question is which option fits your clinical picture and your budget, and that is a conversation rather than a search result. If you have been researching ketamine infusion vs spravato near me and feeling stuck between the two, that is a normal place to land.

A few situations point clearly in one direction:

• Choose Spravato if you need insurance to cover treatment, prefer a standardized protocol, and can commit to the required observation time.
• Consider IV ketamine if you have not responded to other options, want a physician-tuned dose, and can manage the out-of-pocket cost.
• Talk to a clinician first if you are unsure whether your depression even qualifies as treatment-resistant, since that determination shapes everything else.

Solid Foundation Psychiatry offers both esketamine treatment and personalized psychiatric evaluation, along with TMS for patients who want to explore other options. Our team builds a plan around your history rather than a template, and we will tell you honestly if a treatment is not the right fit.

---

Deciding between ketamine infusion and Spravato is not a decision you should have to make alone, and it is not one that should be based on a search engine summary. Solid Foundation Psychiatry provides personalized treatment plans, a collaborative approach to care, and a non-judgmental environment where you can ask hard questions about cost, side effects, and what to expect. Our team offers esketamine treatment alongside a full range of psychiatric services in the Pearland area. Book an appointment with Solid Foundation Psychiatry and get a clear, honest recommendation for your situation.

Frequently Asked Questions

Is Spravato the same thing as ketamine?

No. Spravato contains esketamine, a chemical cousin of ketamine that targets the same brain receptors. Ketamine infusion uses generic ketamine, which is a mixture of two mirror-image molecules. Esketamine is the isolated, more potent form. Both are given under medical supervision, but only Spravato carries FDA approval for treatment-resistant depression. Ketamine infusion remains an off-label option.

Why is Spravato FDA-approved while IV ketamine is off-label?

Spravato went through the FDA’s formal drug approval process, including clinical trials specifically for treatment-resistant depression. Generic ketamine has been used as an anesthetic for decades, so no company has funded the costly trials needed for a psychiatric indication. That means IV ketamine is prescribed off-label, which is legal and common in medicine but carries less standardized oversight than an approved treatment.

Does insurance typically cover Spravato or IV ketamine infusions?

Spravato is more likely to be covered by commercial insurance and Medicare because it is FDA-approved for treatment-resistant depression. IV ketamine infusions are rarely covered. Always verify your specific plan benefits before starting either treatment.

How do the administration methods differ for Spravato and IV ketamine?

Spravato is a nasal spray you administer yourself in a clinic under observation, typically twice weekly during the first month. IV ketamine is delivered through an intravenous line over 40 to 60 minutes, often in a series of six infusions over two to three weeks. Both require monitoring after the dose because of possible dissociation and blood pressure changes.

What are the common side effects of Spravato compared to IV ketamine?

Both can cause dissociation, dizziness, nausea, and temporary blood pressure increases. Spravato’s nasal route may also cause nasal irritation or a bad taste. IV ketamine side effects tend to peak during the infusion and fade within an hour or two. Because of these effects, both treatments require a monitored clinical setting and a ride home afterward.